ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes | Nature Communications,Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor | Nature Medicine,Mitochondrial-nuclear epistasis underlying phenotypic variation in breast cancer pathology | Scientific Reports,Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib | npj Precision Oncology,Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium | Scientific Reports